Complementary and alternative medicine use in patients with haematological malignancies in Europe

Citation

Molassiotis A, Margulies A, Fernandez-Ortega P, Pud D, Panteli V, Bruyns I, Scott J, Gudmundsdottir G, Browall M, Madsen E, Ozden G, Magri M, Selvekerova S, Platin N, Kearney N & Patiraki E (2005) Complementary and alternative medicine use in patients with haematological malignancies in Europe. Complementary Therapies in Clinical Practice, 11 (2), pp. 105-110. https://doi.org/10.1016/j.ctcp.2004.12.005

Abstract
Summary This study reports upon a descriptive cross-sectional survey assessing the use of complementary and alternative medicine (CAM) in patients with haematological cancers. Twelve European countries contributed data from patients with haematological cancers, as part of a larger study. Sixty-eight patients with haematological cancer participated. Among the participants, 26.5% used some form of CAM after the cancer diagnosis. The most common therapies used were homeopathy (38.9%), herbal medicine (22.2%) various psychic therapies, such as use of mediums, healers, rebirthing or past life regression therapy (22.2%). A particular profile of a CAM user was not evident in the sample. Moderate levels of satisfaction with CAM were reported. Patients commonly used CAM to increase the ability of their body to fight cancer and to improve physical and emotional wellbeing. Information about CAM was received mainly from friends or family. As CAM use in patients with haematological malignancies is common, clinicians should assist patients who want to use CAM to make an appropriate decision, and improve communication with them about CAM use in an open and non-judgemental dialogue.

Keywords
Haematologic cancers; myeloma; lymphoma; Cancer Alternative treatment; Alternative Medicine methods; Blood cells Examination; Oncology

Journal
Complementary Therapies in Clinical Practice: Volume 11, Issue 2